Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China · Delayed Price · Currency is CNY 2.900
+0.010 (0.35%)
Jun 12, 2026, 3:04 PM CST
SHE:002390 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 5,500 | 6,106 | 8,629 | 8,560 | 9,136 | 14,423 | |
Market Cap Growth | -18.99% | -29.23% | 0.81% | -6.31% | -36.66% | 7.39% |
Enterprise Value | 5,037 | 5,894 | 8,820 | 8,932 | 9,841 | 15,454 |
Last Close Price | 2.90 | 3.16 | 4.39 | 4.18 | 4.37 | 6.82 |
PE Ratio | 43.04 | 50.77 | 85.11 | 29.80 | 40.72 | 52.86 |
Forward PE | - | 26.33 | 26.33 | 26.33 | 29.35 | 29.35 |
PS Ratio | 1.01 | 1.09 | 1.43 | 1.33 | 1.44 | 2.23 |
PB Ratio | 0.77 | 0.87 | 1.23 | 1.20 | 1.29 | 2.11 |
P/TBV Ratio | 0.91 | 1.01 | 1.46 | 1.41 | 1.52 | 2.49 |
P/FCF Ratio | 8.20 | 9.44 | 16.92 | 13.07 | 21.15 | 70.63 |
P/OCF Ratio | 7.61 | 8.34 | 13.59 | 10.83 | 15.46 | 31.49 |
EV/Sales Ratio | 0.93 | 1.05 | 1.46 | 1.38 | 1.55 | 2.39 |
EV/EBITDA Ratio | 9.96 | 11.94 | 17.82 | 14.41 | 17.33 | 20.14 |
EV/EBIT Ratio | 16.12 | 19.61 | 31.18 | 22.84 | 29.57 | 29.24 |
EV/FCF Ratio | 7.51 | 9.11 | 17.29 | 13.64 | 22.78 | 75.68 |
Debt / Equity Ratio | 0.06 | 0.06 | 0.11 | 0.12 | 0.20 | 0.21 |
Debt / EBITDA Ratio | 0.84 | 0.88 | 1.57 | 1.33 | 2.42 | 1.82 |
Debt / FCF Ratio | 0.64 | 0.68 | 1.54 | 1.28 | 3.22 | 6.93 |
Net Debt / Equity Ratio | -0.10 | -0.10 | -0.03 | 0.00 | 0.07 | 0.12 |
Net Debt / EBITDA Ratio | -1.45 | -1.37 | -0.46 | 0.05 | 0.87 | 1.03 |
Net Debt / FCF Ratio | -1.08 | -1.05 | -0.45 | 0.05 | 1.14 | 3.87 |
Asset Turnover | 0.62 | 0.64 | 0.66 | 0.68 | 0.65 | 0.67 |
Inventory Turnover | 4.84 | 4.73 | 4.85 | 5.15 | 5.22 | 5.76 |
Quick Ratio | 2.81 | 2.63 | 2.23 | 2.02 | 1.65 | 1.56 |
Current Ratio | 3.50 | 3.31 | 2.91 | 2.63 | 2.16 | 2.02 |
Return on Equity (ROE) | 2.87% | 2.73% | 2.20% | 4.98% | 3.86% | 6.23% |
Return on Assets (ROA) | 2.22% | 2.13% | 1.93% | 2.57% | 2.14% | 3.43% |
Return on Invested Capital (ROIC) | 4.05% | 3.81% | 3.40% | 4.74% | 3.75% | 6.51% |
Return on Capital Employed (ROCE) | 4.40% | 4.20% | 3.90% | 5.40% | 4.70% | 7.70% |
Earnings Yield | 2.32% | 1.97% | 1.18% | 3.36% | 2.46% | 1.89% |
FCF Yield | 12.19% | 10.60% | 5.91% | 7.65% | 4.73% | 1.42% |
Dividend Yield | 3.10% | 2.85% | 1.37% | 1.44% | 1.37% | 0.88% |
Payout Ratio | 101.83% | 108.76% | 189.67% | 55.09% | 75.03% | 84.41% |
Buyback Yield / Dilution | -0.44% | 0.26% | 0.67% | -2.41% | -2.79% | -15.32% |
Total Shareholder Return | 2.67% | 3.10% | 2.04% | -0.98% | -1.41% | -14.44% |